[1]
J. Susanto, J. Nugraha, and S. Soedarsono, “IL-4 Level in Rifampicin-Sensitive and Rifampicin-Resistant Lung Tuberculosis Patients”, Indonesian J. Clin. Pathol. Med. Lab., vol. 27, no. 1, pp. 46–50, Dec. 2020.